PI
GILD icon

PEAK6 Investments’s Gilead Sciences GILD Stock Holding History

PEAK6 Investments’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		$8.39M Sell
100,100
-271,400
-73% -$20.7M 0.02% 649
2024
Q2 		$25.5M Buy
371,500
+360,100
+3,159% +$24M 0.07% 232
2024
Q1 		$835K Buy
11,400
+1,400
+14% +$108K ﹤0.01% 2053
2023
Q4 		$810K Buy
+10,000
New +$778K ﹤0.01% 2257
2023
Q3 		– Sell
-17,500
Closed -$1.35M – 4233
2023
Q2 		$1.35M Sell
17,500
-39,600
-69% -$3.16M 0.01% 1492
2023
Q1 		$4.74M Sell
57,100
-168,700
-75% -$14M 0.02% 733
2022
Q4 		$19.4M Sell
225,800
-554,400
-71% -$43.9M 0.11% 174
2022
Q3 		$48.1M Buy
780,200
+210,800
+37% +$13.3M 0.2% 71
2022
Q2 		$35.5M Buy
569,400
+399,200
+235% +$24.7M 0.07% 269
2022
Q1 		$10.1M Sell
170,200
-138,500
-45% -$8.85M 0.02% 693
2021
Q4 		$22.4M Sell
308,700
-98,000
-24% -$6.75M 0.05% 383
2021
Q3 		$28.4M Buy
+406,700
New +$28.6M 0.06% 264
2021
Q1 		– Sell
-359,700
Closed -$21M – 5082
2020
Q4 		$21M Buy
359,700
+71,200
+25% +$4.3M 0.04% 381
2020
Q3 		$18.2M Sell
288,500
-130,600
-31% -$9.06M 0.04% 367
2020
Q2 		$32.2M Sell
419,100
-552,300
-57% -$42.3M 0.11% 173
2020
Q1 		$72.6M Buy
971,400
+886,000
+1,037% +$61.2M 0.43% 37
2019
Q4 		$5.55M Sell
85,400
-18,600
-18% -$1.21M 0.03% 585
2019
Q3 		$6.59M Sell
104,000
-123,000
-54% -$8.04M 0.04% 538
2019
Q2 		$15.3M Buy
227,000
+130,800
+136% +$8.6M 0.1% 214
2019
Q1 		$6.25M Buy
96,200
+27,100
+39% +$1.8M 0.04% 582
2018
Q4 		$4.32M Sell
69,100
-10,800
-14% -$755K 0.03% 728
2018
Q3 		$6.17M Buy
+79,900
New +$6.03M 0.03% 680

Other funds holding GILD

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $935B AUM

PEAK6 Investments's GILD Position: Q4 2023 in Review

PEAK6 Investments sold out of Gilead Sciences (GILD) in Q4 2023, closing a stake of 3,478 shares — an estimated $271K sold.

PEAK6 Investments first reported a position in GILD in Q3 2018 and held it in 19 quarters. The position peaked at $18.8M in Q4 2018. 1,776 funds tracked by Wall St. Rank hold GILD as of Q4 2023.

  • PEAK6 Investments reported no remaining Gilead Sciences position as of Q4 2023 after selling out during the quarter.
  • PEAK6 Investments sold 3,478 Gilead Sciences shares in Q4 2023, an estimated $271K.
  • PEAK6 Investments first reported a position in Gilead Sciences in Q3 2018 and held it in 19 quarters.
  • PEAK6 Investments's Gilead Sciences position peaked at $18.8M in Q4 2018.
  • 1,776 funds tracked by Wall St. Rank held Gilead Sciences as of Q4 2023.

Based on PEAK6 Investments's 13F filing for Q4 2023, filed 13 Feb 2024.